Table 1

Levels of galectin-3 in the sera of patients and healthy controls

DiagnosisNo. of patientsGalectin-3 (ng/ml)
Median5th percentile95th percentileRangePa
Healthy individuals506220184.320–3130.014b
Breast cancer3510023.547820–620
Nonmetastatic84024.2177.320–170
Metastatic271702550220–6200.032c
Gastrointestinal cancer2518520532.420–950
Nonmetastatic5752028020–328
Metastatic203202768420–9500.026c
Lung cancer26171.521.774920–807
Melanoma448.535.121433–243
Ovarian cancer494.536333.135–366
Non-Hodgkin’s lymphoma55021.418720–203
  • a Ps refer to the difference between the cohorts of healthy individuals and all patients with cancerb or to the difference between the groups of patients with nonmetastatic and metastatic diseasec.

  • b Ps refer to the difference between the cohorts of healthy individuals and all patients with cancer

  • c or to the difference between the groups of patients with nonmetastatic and metastatic disease